Alcon
medical company
ALC SIX Swiss · home listing
ALC NYSE
ISIN CH0432492467 SEC CIK 1167379 LEI 549300LDT5AP8S0NBM78
Follow Alcon
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $10.4B | $980M |
| FY24 | $9.9B | $1B |
| FY23 | $9.5B | $974M |
| FY22 | $8.7B | $335M |
| FY21 | $8.3B | $376M |
| FY20 | $6.8B | −$531M |
| FY19 | $7.5B | −$656M |
| FY18 | $7.2B | −$227M |
| FY17 | $6.8B | $256M |
| FY16 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 55.2% | 13.1% | 9.4% |
| FY24 | 55.6% | 14.3% | 10.3% |
| FY23 | 55.5% | 11% | 10.3% |
| FY22 | 54.5% | 7.7% | 3.8% |
| FY21 | 56.1% | 7% | 4.5% |
| FY20 | 43% | −7.1% | −7.8% |
| FY19 | 48.8% | −2.5% | −8.7% |
| FY18 | 44.6% | −3.5% | −3.2% |
| FY17 | 47.2% | −1.1% | 3.8% |
| FY16 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $1.7B |
| FY24 | $1.6B |
| FY23 | $730M |
| FY22 | $581M |
| FY21 | $645M |
| FY20 | $344M |
| FY19 | $367M |
| FY18 | $616M |
| FY17 | $803M |
| FY16 | - |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $166M | $676M |
| FY24 | $130M | $0 |
| FY23 | $116M | $0 |
| FY22 | $100M | - |
| FY21 | $54M | - |
| FY20 | $0 | - |
| FY19 | $0 | - |
| FY18 | - | - |
| FY17 | - | - |
| FY16 | - | - |
- Alcon
- Healthcare median
Show the numbers
| Year | Alcon | Healthcare median |
|---|---|---|
| FY25 | 9.4% | −30.6% |
| FY24 | 10.3% | −47% |
| FY23 | 10.3% | −58% |
| FY22 | 3.8% | −80.4% |
| FY21 | 4.5% | −71.9% |
| FY20 | −7.8% | −62.2% |
| FY19 | −8.7% | −46.3% |
| FY18 | −3.2% | −49.6% |
| FY17 | 3.8% | −45.9% |
| FY16 | - | −36% |